RecruitingNCT03275480
Institut Paoli Calmettes Myelodysplastic Syndromes Database
Sponsor
Institut Paoli-Calmettes
Enrollment
10,000 participants
Start Date
Jan 18, 2016
Study Type
OBSERVATIONAL
Conditions
Summary
Database of Institut Paoli-Calmettes patients diagnosed with Myelodysplastic Syndromes
Eligibility
Min Age: 18 Years
Inclusion Criteria1
- Patient with a diagnosis of Myelodysplastic Syndromes
Exclusion Criteria1
- None
Interested in this trial?
Get notified about updates and connect with the research team.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT03275480
Related Trials
Comprehensive Molecular and Clinical Evaluation of Pediatric and Adult MDS
NCT053507481 location
Pacritinib, a Kinase Inhibitor of CSF1R, IRAK1, JAK2, and FLT3, in Adults and Pediatric Participants 12 Years of Age or Older With Myelodysplastic Syndromes or Myelodysplastic/Myeloproliferative Neoplasms
NCT063031931 location
Collection of Blood, Bone Marrow, Skin, Saliva, and Stool Samples From Healthy Volunteers Used for Comparative Analysis of Myeloid Malignancies
NCT055881541 location
Study of MGUS, Smoldering Myeloma, Early MDS and CLL to Assess Molecular Events of Progression and Clinical Outcome
NCT022695927 locations
Study of DISC-0974 (RALLY-MF) in Participants With Myelofibrosis or Myelodysplastic Syndrome and Anemia
NCT0532019824 locations